References:
  1. Rychik J, Tian Z. Fetal Cardiovascular Imaging E-Book: Expert Consult Premium. Elsevier Health Sciences; 2011. 529 p.
  2. Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo Júnior E. Fetal cardiac arrhythmias: Current evidence. Ann Pediatr Cardiol. 2018;11(2):148-163. doi:10.4103/apc.APC_134_17
  3. Kleinman CS, Nehgme R, Copel JA. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R (Eds.), Maternal-Fetal Medicine (4th ed). Saunders; 1999. p. 301-318.
  4. Caruso E, Farruggio S, Agati S, Di Mambro C. Fetal Bradyarrhythmias: Etiopathogenesis, Diagnosis and Treatment: Between Literature Review and Experience of a Tertiary Center. Congenital Heart Disease . 2021;16(4):309-331. doi:https://doi.org/10.32604/chd.2021.015470
  5. Yagel S, Silverman NH, Gembruch U. Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis, and perinatal management of cardiac diseases. Third edition. CRC Press. 2019. doi: 10.1201/9780429461118.
  6. Kleinman CS, Hobbins JC, Jaffe CC, Lynch DC, Talner NS. Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics. 1980;65(6):1059-1067.
  7. Strasburger JF, Wakai RT. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol. 2010;7(5):277-290. doi:10.1038/nrcardio.2010.32
  8. Yuan SM, Xu ZY. Fetal arrhythmias: prenatal evaluation and intrauterine therapeutics. Ital J Pediatr. 2020;46(1):21. Published 2020 Feb 12. doi:10.1186/s13052-020-0785-9
  9. Araujo J EA, Bravo-Valenzuela NJM, Peixoto AB, editors. Perinatal cardiology Part 1. Bentham Science Publishers; 2020.
  10. Chih WL, Olisova K, Tung YH, Huang YL, Chang TY. Fetal arrhythmias case series: Experiences from a fetal screening center in Taiwan. Taiwan J Obstet Gynecol. 2023;62(3):480-484. doi:10.1016/j.tjog.2023.01.007
  11. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol. 1991;17(6):1360-1366. doi:10.1016/s0735-1097(10)80148-2
  12. Maeno Y, Himeno W, Saito A, et al. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience. Heart. 2005;91(8):1075-1079. doi:10.1136/hrt.2003.033407
  13. Lopes LM, Tavares GM, Damiano AP, et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution [published correction appears in Circulation. 2008 Oct 14;118(16): e671]. Circulation. 2008;118(12):1268-1275. doi:10.1161/CIRCULATIONAHA.107.735118
  14. Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT. Electrophysiological characteristics of fetal atrioventricular block. J Am Coll Cardiol. 2008;51(1):77-84. doi:10.1016/j.jacc.2007.06.060
  15. Bravo-Valenzuela NJ, Araujo Júnior E. Inappropriate fetal sinus tachycardia at 9 weeks of gestation. Ann Pediatr Cardiol. 2022;15(4):399-403. doi:10.4103/apc.apc_130_21
  16. Ciardulli A, D’Antonio F, Magro-Malosso ER, et al. Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(7):787-794. doi:10.1111/aogs.13338
  17. Trucco SM, Jaeggi E, Cuneo B, et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011;57(6):715-723. doi:10.1016/j.jacc.2010.09.044
  18. Cuneo BF. Fetal Bradycardia. In: Yagel S, Silverman NH, Gembruch U, editors. Fetal Cardiology. 3rd ed. Taylor and Francis, LLC; Boca Raton, FL, USA: 2019.
  19. Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv. 1985;40(2):61-68. doi:10.1097/00006254-198502000-00002
  20. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110(12):1542-1548. doi:10.1161/01.CIR.0000142046.58632.3A
  21. Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol. 2009;103(8):1102-1106. doi:10.1016/j.amjcard.2008.12.027
  22. Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010;62(4):1138-1146. doi:10.1002/art.27308
  23. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J. 1991;65(1):46-48. doi:10.1136/hrt.65.1.46
  24. Jennifer NA, Edward KR. Diagnosis and Treatment of Fetal Tachyarrhythmias. US Cardiology. 2006;3(2):1-5.
  25. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003;89(8):913-917. doi:10.1136/heart.89.8.913
  26. Singh GK. Management of Fetal Tachyarrhythmias. Curr Treat Options Cardiovasc Med. 2004;6(5):399-406. doi:10.1007/s11936-004-0023-6
  27. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998;79(6):576-581.
  28. Simpson LL. Fetal supraventricular tachycardias: diagnosis and management. Semin Perinatol. 2000;24(5):360-372. doi:10.1053/sper.2000.1654
  29. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol. 2000;96(4):575-581. doi:10.1016/s0029-7844(00)00996-0
  30. Ebenroth ES, Cordes TM, Darragh RK. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol. 2001;22(6):483-487. doi:10.1007/s002460010279
  31. Maeno Y, Hirose A, Kanbe T, Hori D. Fetal arrhythmia: prenatal diagnosis and perinatal management. J Obstet Gynaecol Res. 2009;35(4):623-629. doi:10.1111/j.1447-0756.2009.01080.x
  32. Hornberger LK, Sahn DJ. Rhythm abnormalities of the fetus. Heart. 2007;93(10):1294-1300. doi:10.1136/hrt.2005.069369
  33. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000;101(23):2721-2726. doi:10.1161/01.cir.101.23.2721
  34. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 2002;19(2):158-164. doi:10.1046/j.0960-7692.2001.00562.x
  35. Broom E, Thomas JT, Petersen S, et al. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center. Fetal Diagn Ther. 2021;48(11-12):794-800. doi:10.1159/000519911
  36. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 2002;19(2):158-164. doi:10.1046/j.0960-7692.2001.00562.x
  37. Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo Júnior E. Fetal cardiac arrhythmias: Current evidence [published correction appears in Ann Pediatr Cardiol. 2018 Sep-Dec;11(3):332]. Ann Pediatr Cardiol. 2018;11(2):148-163. doi:10.4103/apc.APC_134_17
  38. Strasburger JF. Prenatal diagnosis of fetal arrhythmias. Clin Perinatol. 2005;32(4):891-viii. doi:10.1016/j.clp.2005.09.011
  39. Cuneo BF, Strasburger JF, Niksch A, Ovadia M, Wakai RT. An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease. J Matern Fetal Neonatal Med. 2009;22(3):233-238. doi:10.1080/14767050802488220